Skip Navigation



Hum. Reprod. Advance Access published online on July 29, 2005

Human Reproduction, doi:10.1093/humrep/dei227
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/12/3348    most recent
dei227v2
dei227v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Condous, G.
Right arrow Articles by Bourne, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Condous, G.
Right arrow Articles by Bourne, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
Received February 28, 2005
Revised May 20, 2005
Accepted May 31, 2005

Article

Do levels of serum cancer antigen 125 and creatine kinase predict the outcome in pregnancies of unknown location?

G. Condous 1*, E. Kirk 1, A. Syed 1, B. Van Calster 2, S. Van Huffel 2, D. Timmerman 3, and T. Bourne 1

1 Early Pregnancy Unit, St George’s Hospital Medical School, London, UK
2 Department of Electrical Engineering, K.U.Leuven, Belgium
3 Department of Obstetrics and Gynaecology, University Hospital Gasthuisberg, K.U.Leuven, Belgium

* To whom correspondence should be addressed.
G. Condous, E-mail: gcondous{at}hotmail.com


   Abstract

BACKGROUND: The aim of this study was to evaluate the role of maternal serum cancer antigen 125 (CA 125) and creatine kinase (CK) levels in predicting the outcome of pregnancies of unknown location (PUL). METHODS: Prospective observational study. Women classified as PUL were recruited. Final outcome of each PUL was established: failing PUL, intrauterine pregnancy (IUP), ectopic pregnancy (EP) or persisting PUL. The persisting PUL group almost certainly represent ultrasonically missed EP and were included in EP group. Serum CK and CA 125 were measured at 0 and 48 h. The values at presentation and the change in levels after 2 days were used in the analysis. We incorporated the most significant of variables into a multinomial logistic regression model to predict all outcomes. The performance of this model was evaluated using receiver operating characteristic (ROC) curves. RESULTS: In all, 4698 consecutive women were scanned; 403 were classified as PUL, 27 were lost to follow-up. Of the 376 women eligible, 297 had complete data and therefore were recruited. Mean age and mean gestation were 30.0 years and 43.3 days respectively. Final outcomes: 153 failing PUL (51.5%), 116 IUP (39.1%) and 28 EP (9.4%). Mean serum CK levels at 0 and 48 h were 88.5 and 86.8 IU/l respectively. Mean serum CA 125 levels at 0 and 48 h were 43.8 and 40.1 kIU/l respectively. 81.1% of women had CK and CA 125 ratios (CK 48 h/CK 0 h, CA 125 48 h/CA125 0 h) between 0.7 and 1.3. CA 125 ratio was the only significant variable in the thee outcome groups (P < 0.0001). Logistic regression analysis incorporating CA 125 ratio gave an area under ROC curve of 0.782 (SE = 0.041) for failing PUL, 0.768 (SE = 0.043) for IUP and 0.560 (SE = 0.078) for EP. This model was capable of distinguishing failing PUL from IUP, but was not able to detect EP. CONCLUSIONS: Absolute levels of serum CK and CA 125 at the defined times cannot be used to predict the outcome of PUL. Although the CA 125 ratio when incorporated into logistic regression model can distinguish failing PUL from IUP, its inability to detect the high risk PUL, i.e. the developing EP, renders it inappropriate for use in the clinical setting.

Keywords: cancer antigen 125/creatine kinase/ectopic pregnancy/pregnancy of unknown location/transvaginal ultrasonography.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
E. Kirk, A. T. Papageorghiou, B. Van Calster, G. Condous, N. Cowans, S. Van Huffel, D. Timmerman, K. Spencer, and T. Bourne
The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location'
Hum. Reprod., October 1, 2009; 24(10): 2451 - 2456.
[Abstract] [Full Text] [PDF]


Home page
The Obstetrician and GynaecologistHome page
H. Sagili and K. Mohamed
Pregnancy of unknown location: an evidence-based approach to management
Obstet Gynaecol (Lond), October 1, 2008; 10(4): 224 - 230.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Condous, E. Kirk, and T. Bourne
Reply: Ultrasound diagnosis of ectopic pregnancy
Hum. Reprod., May 1, 2007; 22(5): 1494 - 1494.
[Full Text] [PDF]


Home page
Hum ReprodHome page
G. Condous, E. Kirk, C. Lu, B. Van Calster, S. Van Huffel, D. Timmerman, and T. Bourne
There is no role for uterine curettage in the contemporary diagnostic workup of women with a pregnancy of unknown location
Hum. Reprod., October 1, 2006; 21(10): 2706 - 2710.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.